Endocrinology has evolved from a crude understanding of the pathophysiology of various endocrine disorders with a focus on hormone replacement therapy to an improved understanding of the endocrine system and shift towards targeting the root causes of hormone dysfunction. Current endocrinology dynamics the REACH team is tracking include:
- Prominent industry focus on developing disease modifying drugs (e.g., Tzield and cell therapies for Type 1 Diabetes, Voxzogo for achondroplasia, gene therapy for Congenital Adrenal Hyperplasia)
- Advancements in genetic understanding of pediatric endocrine disorders
- The growing body of evidence against endocrine-disrupting chemicals and associated health risks
Search Endocrinology diseases we cover
